phytocannabinoids use cannabidivarin (CBDV) in the treatment of epilepsy

fitocanabinoide use cannabidivarin (CBDV) in the treatment of epilepsy. This invention relates to the use of fitocanabinoide cannabidivarin (CBDV), and combinations of CBDV to fitocanabinoide tetrahydrocannabivarin (THCV) and cannabidiol (CBD) in the treatment of epilepsy. the invention further relates to the use of CBDV fitocanabinoide in combination with standard anti-epileptics (saeds). preferably it is one of the SAED ethosuximide, valproate oufenobarbital.